| Variables | NLR-CAR 0 | NLR-CAR 1 | NLR-CAR 2 | P value |
| Sex |
|
|
|
|
| Female | 11 (39.3%) | 8 (28.6%) | 9 (32.1%) | 0.799 |
| Male | 14 (42.1%) | 7 (21.1%) | 12 (36.4%) | |
| Age |
|
|
|
|
| ≤18 months | 19 (76.0%) | 5 (20.0%) | 1 (4.0%) | 0.000 |
| >18 months | 6 (16.7%) | 10 (27.8%) | 20 (55.6%) | |
| ALB |
|
|
|
|
| <35 g/L | 9 (60.0%) | 4 (26.7%) | 2 (13.3%) | 0.104 |
| ≥35 g/L | 16 (34.8%) | 11 (23.9%) | 19 (41.3%) | |
| LDH |
|
|
|
|
| ≤400 U/L | 22 (56.4%) | 11 (28.2%) | 6 (15.4%) | 0.000 |
| >400 U/L | 3 (13.6%) | 4 (18.2%) | 15 (68.2%) | |
| WBC |
|
|
|
|
| ≤10 × 109/L | 20 (52.6%) | 12 (31.6%) | 6 (15.8%) | 0.000 |
| >10 × 109/L | 5 (21.7%) | 3 (13.0%) | 15 (65.2%) | |
| Tumor size |
|
|
|
|
| ≤5 cm | 18 (78.3%) | 4 (17.4%) | 1 (4.3%) | 0.000 |
| >5 cm | 7 (18.4%) | 11 (28.9%) | 20 (52.6%) | |
| Site |
|
|
|
|
| Adrenal | 6 (33.3%) | 6 (33.3%) | 6 (33.3%) | 0.536 |
| Non-Adrenal | 19 (44.2%) | 9 (20.9%) | 15 (34.9%) | |
| Chemotherapy |
|
|
|
|
| Yes | 19 (43.2%) | 11 (25.0%) | 14 (31.8%) | 0.772 |
| No | 6 (35.3%) | 4 (23.5%) | 7 (41.2%) | |
| INSS Stage |
|
|
|
|
| I-II | 17 (65.4%) | 6 (23.1%) | 3 (11.5%) | 0.001 |
| III-IV | 8 (22.9%) | 9 (25.7%) | 18 (51.4%) |